Nutrition 21 announces supply & licensing agreement with CNS
CNS to use Chromax Chromium Picolinate in FiberChoice Weight Management Chewable Tablets.
19/12/05 Nutrition 21, Inc., has announced a supply & licensing agreement with CNS, Inc, the Breathe Right® * company, for the exclusive use of Chromax® chromium picolinate as an ingredient in CNS’ newest product in the FiberChoice® * franchise – FiberChoice Weight Management™ * chewable tablets. The product dosage will include 4 grams of fiber, 200 mcg of chromium as Chromax chromium picolinate, and green tea.
Nutrition 21 has been the driving force behind chromium science and licenses chromium picolinate for its patented nutritional uses to vitamin, supplement and food marketers.
Nutrition 21 is a nutritional bioscience company and the maker of chromium-based supplements with health benefits substantiated by clinical research. The company markets Chromax chromium picolinate, http://www.chromax.com/, which is the most-studied form of the essential mineral chromium. Nutrition 21 also developed Diachrome®, which is available through diabetes educators or at http://www.diachrome.com. Nutrition 21 holds 36 patents for nutrition products and uses, 27 of which are for chromium compounds and their uses.
CNS, based in Minneapolis, designs and markets consumer health care products, including Breathe Right® nasal strips and FiberChoice® dietary fiber supplements. The company focuses on products that address important consumer needs within the aging well/self care market, including better breathing and digestive health.
